SAFER: A Programme of Research to Determine if Intermittent Single-Lead ECG Screening for Atrial Fibrillation Reduces the Risk of Stroke.
Repository URI
Repository DOI
Change log
Authors
Abstract
This article describes the SAFER (Screening for Atrial Fibrillation with ECG to Reduce stroke) programme that was established to determine whether intermittent screening for atrial fibrillation with a single-lead electrocardiogram reduces the risk of stroke and other key outcomes such as death, dementia and cardiovascular disease. The programme comprises feasibility studies, a pilot trial, a randomised controlled trial, qualitative studies and an economic analysis. Recruitment and screening for the trial have been completed, and it is anticipated that follow-up will finish in 2027.
Description
Keywords
32 Biomedical and Clinical Sciences, 3201 Cardiovascular Medicine and Haematology, 3202 Clinical Sciences, Prevention, Health Services, Cardiovascular, Stroke, Heart Disease, Clinical Research, Aging, Neurosciences, Cerebrovascular, Brain Disorders, 6.3 Medical devices, 4.2 Evaluation of markers and technologies, Stroke, Cardiovascular, 3 Good Health and Well Being
Journal Title
Thromb Haemost
Conference Name
Journal ISSN
0340-6245
2567-689X
2567-689X
Volume Title
Publisher
Thieme
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as All Rights Reserved
Sponsorship
European Commission Horizon 2020 (H2020) ERC (847770)
National Institute for Health Research (NIHR) (via Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)) (PGfAR RP-PG-0217-20007)
National Institute for Health Research (NIHR) (via Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)) (PGfAR RP-PG-0217-20007)